Lung Cancer Research Foundation

Analysis

Lung Cancer Research Foundation is a registered charity in United States, based in Philadelphia, PA. It received its IRS tax-exemption ruling in December 2005, 21 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Lung Cancer Research Foundation reported income of $6.4m and spending of $6.4m, spending 101% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $5.3m to $6.4m (+20%), an average of +4.6% a year. The sharpest change came in the year to December 2021, when income rose by 16%. Over the whole period it spent 97% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Lung Cancer Research Foundation sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 93rd percentile, and in the 92nd percentile within PA. Charities of a similar size with the same main cause include Big Sky Care Connect ($6.4m), Bryan Foundation ($6.4m) and Visiting Nurse at Highland Inc ($6.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. Compensation of current officers, directors and key employees was $507k (7.9% of expenses). Other salaries and wages came to $1.5m. At year end it held assets of $6.9m against liabilities of $3.3m, net assets of $3.6m. It reported 21 employees.